1,710 trials (keyword fallback)
Sjögren's Syndrome · Sjogren's Syndrome
Primary: Change From Baseline to Week 12 in ESSDAI Score — -5.60; -5.29 score on a scale
Sjogren's Syndrome
Primary: Blood Cell Gene Expression — -0.0291486; 0.1330903; 0.2509076; 0.06726222 log 2 fold change — p=0.0000496
Sjogren's Syndrome
Primary: Percentage of Participants With a Clinically Relevant Decrease in European League Against Rheumatism (EULAR) Sjogren's Syndrome Disease Activity Index (ESSDAI) Score…
Sjogren's Syndrome · Dry Eye
Primary: Mean Change in Cornea Staining — -1.78 units on a scale
Photosensitive Epilepsy
Primary: % Change in Frequency of Handwaving Episodes — -66.2 % change in hand waving episodes — p=<0.001
Primary Sjögren's Syndrome
Primary: Number of Participants With Primary Sjögren's Syndrome With Adverse Events and Death up to Day 85 — 20; 8; 1; 0 count of participants
Primary Sjögren's Syndrome
Primary: Change in ESSDAI Total Score — -3.77; -5.54; 11.52; 13.12 score on a scale
Sjogren's Syndrome
Primary: Percentage of Participants Fulfilling Protocol-Specified Response Criteria at Week 12, as Compared to Baseline — 42.9; 43.2; 35.1; 26.5 percentage of participants…
Sjögren's Syndrome
Primary: Population 1: Change From Baseline in ESSDAI at Day 169 — -4.1; -6.3 Score on scale
Xerostomia · Sjogren's Syndrome
Primary: Overall Improvement Rate in Dry Mouth Symptoms — 26.0; 20.0; 44.0; 27.1 percentage of participants
Sjogren-Larsson Syndrome
Primary: Visual Index Ichthyosis Severity (VIIS) Scaling Score as Assessed by the Investigator in ADX-102 Treated Patients — -0.7 units on a scale
Primary Sjögren's Syndrome
Primary: Proportion of Participants With a 1 Point or Greater Change on the Salivary Gland Ultrasound (SGUS) Score for Parotid and Submandibular Glands — 0; 0 Participants
Autoimmune Disorder · Rheumatoid Arthritis · Systemic Lupus Erythematosus
Primary: The Percent of Participants With mCLASI Response at Week 24 and Corticosteroid (CS) < 10 mg/Day at Week 20 and Week 24 - SLE — 60.0; 33.3 Percentage of participants…
Sjögren Syndrome
Primary: Cohort 1: Change in EULAR Sjögren Syndrome Disease Activity Index (ESSDAI) Score From Baseline at 24 Weeks as Compared to Placebo — -4.0; -7.0; -5.4; -6.9 Unit on a…
Primary Sjögren's Syndrome
Primary: Change From Baseline in EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) — 12.0; 11.8; 10.6; 11.0 units on a scale — p=0.397